Imidazoles and Benzimidazoles as Tubulin-Modulators for Anti-Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|22|11|1312-1323

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.11, 2015-04, pp. : 1312-1323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potentiation of Anti-Cancer Treatment by Modulators of Energy Metabolism

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 3, 2013-03 ,pp. : 313-330

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Phosphatidylserine in Anti-Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 15, Iss. 23, 2009-08 ,pp. : 2719-2723

Bentham Science Publishers

Access to resources Recommend Favorite

Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs

By  

Current Medicinal Chemistry, Vol. 24, Iss. 30, 2017-10 ,pp. : 3283-3309

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor Tyrosine Kinases as Target for Anti-Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. : 1959-1972

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Cancer Therapy: Targeting the Mevalonate Pathway

By  

Current Cancer Drug Targets, Vol. 6, Iss. 1, 2006-02 ,pp. : 15-37

Bentham Science Publishers

Access to resources Recommend Favorite